title: [The diagnosis of prostate cancer from the clinical guidelines].
abstract: OBJECTIVE
  To compare methodology and recommendations for the diagnosis of prostate cancer between the different clinical  Guidelines currently existent.
  
  
  METHODS
  We searched for clinical practice Guidelines published in the period 2007-2009 in the web pages of the  urological  scientific associations, National Guideline clearinghouse, CMA infobase, and Trip database, as well as Pub Med. We found 4  clinical practice guidelines matching the search criteria.
  
  
  RESULTS
  All guidelines have been developed by a multidisciplinary team, performing a previous systematic review. All of  them except the AUA translate the scientific evidence in recommendations, although each of them uses a different classification. Only one of them has been evaluated  using the AGREE method. There are differences in the recommendation and use of diagnostic tests (PSA, digital rectal examination and prostatic  biopsy) due to the fact that as a general rule they are based on low level scientific evidence.
  
  
  CONCLUSIONS
  Recommendations for the diagnosis of prostate cancer in all clinical practice guidelines are based on low  levels of evidence, except in the use of antibiotic prophylaxis and anesthesia to perform a biopsy.
authors: Servicio de Urología, Hospital Universitario Gregorio Marañón, Madrid, España. felipeherranz@telefonica.net
authors: Felipe
authors: F
authors: Herranz Amo
authors: Carlos
authors: C
authors: Hernández Fernández
mesh_terms: D000230:Adenocarcinoma / Q000175:diagnosis*; D000772:Anesthesia, Local; D019072:Antibiotic Prophylaxis; D001707:Biopsy, Needle / Q000379:methods / Q000706:statistics & numerical data; D005060:Europe; D019317:Evidence-Based Medicine; D006801:Humans; D008297:Male; D010173:Palpation / Q000706:statistics & numerical data; D017410:Practice Guidelines as Topic; D011237:Predictive Value of Tests; D017430:Prostate-Specific Antigen / Q000097:blood; D011471:Prostatic Neoplasms / Q000175:diagnosis*; D012306:Risk
chemical_list: D017430:Prostate-Specific Antigen